[HTML][HTML] ERR1-and PGC1α-associated mitochondrial alterations correlate with pan-cancer disparity in African Americans
DWB Piyarathna, A Balasubramanian… - The Journal of …, 2019 - Am Soc Clin Investig
The Journal of clinical investigation, 2019•Am Soc Clin Investig
BACKGROUND African American patients have higher cancer mortality rates and shorter
survival times compared with European American patients. Despite a significant focus on
socioeconomic factors, recent findings strongly argue the existence of biological factors
driving this disparity. Most of these factors have been described in a cancer-type specific
context rather than a pan-cancer setting. METHODS A novel in silico approach based on
Gene Set Enrichment Analysis (GSEA) coupled to transcription factor enrichment was …
survival times compared with European American patients. Despite a significant focus on
socioeconomic factors, recent findings strongly argue the existence of biological factors
driving this disparity. Most of these factors have been described in a cancer-type specific
context rather than a pan-cancer setting. METHODS A novel in silico approach based on
Gene Set Enrichment Analysis (GSEA) coupled to transcription factor enrichment was …
BACKGROUND
African American patients have higher cancer mortality rates and shorter survival times compared with European American patients. Despite a significant focus on socioeconomic factors, recent findings strongly argue the existence of biological factors driving this disparity. Most of these factors have been described in a cancer-type specific context rather than a pan-cancer setting.
METHODS
A novel in silico approach based on Gene Set Enrichment Analysis (GSEA) coupled to transcription factor enrichment was carried out to identify common biological drivers of pan-cancer racial disparity using The Cancer Genome Atlas data set. Mitochondrial content in patient tissues was examined using a multi-cancer tissue microarray approach (TMA).
RESULTS
Mitochondrial oxidative phosphorylation was uniquely enriched in tumors from African American patients compared with tumors of various cancer types from European American patients. Tumors from African American patients also showed strong enrichment for the ERR1-PGC1α–mediated transcriptional program, which has been implicated in mitochondrial biogenesis. TMA analysis revealed that cancers from African American patients harbor significantly more mitochondria compared with the same cancers from European American patients.
CONCLUSION
These findings highlight changes in mitochondria as a common distinguishing feature among tumors from African American versus European American patients in a pan-cancer setting, and provide the rationale for the repurposing of mitochondrial inhibitors to treat cancers from African American patients.
FUNDING
This research was partially supported by National Institutes of Health grants NIH U01 CA167234, NIH 1 U01 CA179674-01A1, 5R01GM11402903, 1U01CA23548701, U01 CA167234, R01CA220297, and R01CA216426; pilot and shared resources support from Dan L. Duncan Cancer Center grant P30 CA125123; and NCI SPORE pilot grant NIH P50 CA186784. It was also partially supported by the Diana Helis Henry Medical Research Foundation; the Brockman Foundation; Agilent Technologies; Department of Defense grants W81XWH-12-1-0130 and W81XWH-12-1-0046; Cancer Prevention Research Institute of Texas grant RP120092; a Prostate Cancer Foundation Challenge Award; National Science Foundation grant DMS-1545277; and American Cancer Society grant 127430-RSG-15-105-01-CNE.
The Journal of Clinical Investigation